Oxoiron(IV) Porphyrin π-Cation Radical Complexes
romethane/n-hexane.46 (TMP)FeIIINO3 and (TMTMP)FeIIINO3 were
obtained by mixing (TMP)FeIIIOH and (TMTMP)FeIIIOH in toluene
with 1 M nitric acid, and purified by recrystallization from ether/n-
UV-vis. (CH2Cl2, 25 °C), 412, 511, 572 and 692 nm. [(TMP)FeIII(5-
1
MeIm)]ClO4; H NMR (CD2Cl2, 25 °C), 13.0 and 13.9 (meta-H),
4.4 (para-Me), 31.7 (pyrrole-H), -18.6 (5-MeIm 2-Me), 31.7 (5-
MeIm 4-H), 22.0 (5-MeIm 5-Me), 100.8 (5-MeIm N-H). UV-vis.
(CH2Cl2, 25 °C), 412, 510, 572, and 692 nm. [(TMTMP)FeIII-
hexane.47 (TMP)FeIII(NO3); H NMR (CD2Cl2, 25 °C), 4.0 and 6.2
1
(ortho-Me), 15.3 and 16.5 (meta-H), 4.3 (para-Me), 74.0 (pyrrole-H).
UV-vis. (CH2Cl2, 25 °C), 412, 514, 580, 647, and 691 nm.
(TMTMP)FeIII(NO3); 1H NMR (CD2Cl2, 25 °C), -49.6 (meso-H), 5.1
and 8.4 (ortho-Me), 12.9 and 13.3 (meta-H), 6.3 (para-Me), 58.7
(pyrrole-Me). UV-vis. (CH2Cl2, 25 °C), 388, 506, 532, and 637 nm.
Synthesis. Iron(III) Phenolate Complexes. Iron(III) phenolate
complexes were prepared by the published method.48 (TMP)FeIIIOH
and (TMTMP)FeIIIOH were dissolved in toluene and 1 equiv of
phenol derivative (4-nitrophenol, pentafluorophenol, 3,4,5-trifluo-
rophenol, or 3-fluoro-4-nitrophenol) was added with stirring. The
green or red solution changed to brown as the phenol dissolved.
The solution was evaporated to dryness, and the residue was purified
by crystallization from ether/hexane. Microcrystals of the iron(III)
phenol complex were collected by filtration. (TMP)FeIII(4-NO2-
PhO); 1H NMR (CD2Cl2, 25 °C), 3.0 and 5.2 (ortho-Me), 12.5 and
13.5 (meta-H), 3.7 (para-Me), 79.1 (pyrrole-H), -91.4 (phenol
ortho-H), 83.0 (phenol meta-H). UV-vis. (CH2Cl2, 25 °C), 420,
497, 559, 635, and 667 nm. (TMP)FeIII(F5-PhO); 1H NMR (CD2Cl2,
25 °C), 2.9 and 5.2 (ortho-Me), 12.7 and 13.6 (meta-H), 3.8 (para-
Me), 78.7 (pyrrole-H). UV-vis. (CH2Cl2, 298 K), 415, 500, 566,
642, and 673 nm. (TMP)FeIII(3,4,5-F3-PhO); 1H NMR (CD2Cl2, 25
°C), 3.0 and 5.1 (ortho-Me), 12.3 and 13.3 (meta-H), 3.7 (para-
Me), 79.8 (pyrrole-H), -101.0 (phenol ortho-H). UV-vis. (CH2Cl2,
25 °C), 420, 490, 557, 620, and 666 nm. (TMP)FeIII(3-F-4-NO2-
PhO); 1H NMR (CD2Cl2, 25 °C), 3.1 and 5.2 (ortho-Me), 12.7 and
13.7 (meta-H), 3.8 (para-Me), 78.9 (pyrrole-H), -85.1 and -81.5
(phenol ortho-H), 72.4 (phenol meta-H). 19F NMR (CD2Cl2, 25 °C),
58.4 (meta-F). UV-vis. (CH2Cl2, 25 °C), 419, 500, 560, 640, and
668 nm. (TMTMP)FeIII(F5-PhO); 1H NMR (CD2Cl2, 25 °C), -40.5
(meso-H), 4.8 and 7.4 (ortho-Me), 11.9 and 12.0 (meta-H), 6.0
(para-Me), 47.7 (pyrrole-Me), -83.1 and -79.9 (phenol ortho-
H), 67.9 (phenol meta-H). UV-vis. (CH2Cl2, 25 °C), 371, 398,
1
(Im)]ClO4; H NMR (CD2Cl2, 25 °C), -16.6 (meso-H), 4.8 and
8.0 (ortho-Me), 13.5 and 14.4 (meta-H), 5.5 (para-Me), 69.2
(pyrrole-Me), -16.1 (Im 2-H), 31.2 (Hm 4-H), 82.6 (Im 5-H), 98.5
(Im N-H). UV-vis. (CH2Cl2, 25 °C), 385, 503, and 626 nm.
1
[(TMTMP)FeIII(2-MeIm)]ClO4; H NMR (CD2Cl2, 25 °C), -31.9
(meso-H), 5.1 and 8.8 (ortho-Me), 13.8 and 14.5 (meta-H), 6.2
(para-Me), 70.0 (pyrrole-Me), 17.5 (2-MeIm 2-Me), 35.9 (2-MeIm
4-H), 66.6 (2-MeIm 5-H), 110.0 (2-MeIm N-H). UV-vis. (CH2Cl2,
298K), 385, 503, and 626 nm. [(TMTMP)FeIII(5-MeIm)]ClO4; 1H
NMR (CD2Cl2, 298 K), -20.1 (meso-H), 5.0 and 8.2 (ortho-Me),
13.7 and 14.5 (meta-H), 5.8 (para-Me), 70.3 (pyrrole-Me), -15.4
(5-MeIm 2-H), 32.6 (5-MeIm 4-H), 20.7 (5-MeIm 5-H), 99.5 (5-
MeIm N-H). UV-vis. (CH2Cl2, 25 °C), 385, 503, and 626 nm.
Oxoiron(IV) Porphyrin Complexes. Oxoiron(IV) porphyrin
complexes were prepared as previously described.45 (TMP)-
FeIII(ClO4)2 or (TMTMP)FeIII(ClO4)2, which was prepared from the
oxidation of (TMP)FeIIIOH or (TMTMP)FeIIIOH with solid ferric
perchlorate, in dichloromethane-d2 was transferred through a short
basic alumina (20% water) column (0.5 × 1 cm) at ambient
temperature, directly into a NMR tube in dry ice-acetone bath. One
equiv of 1-MeIm or 1,2-DiMeIm in dichloromethane-d2 was slowly
added to the cooled solution in the NMR tube.
Ozone Oxidation of Iron(III) Porphyrin. For NMR or EPR
measurement, iron(III) porphyrin complexes were dissolved in
dichloromethane and placed in NMR or EPR cell. The solution
was cooled by a dry ice acetone bath. Ozone gas was slowly
bubbled in the solution with a gastight syringe. With the formation
of oxoiron(IV) porphyrin π-cation radical complexes, the brown
1
solution changed to green. The oxidations were monitored by H
NMR or EPR spectra. For UV-visible absorption spectra, the
oxidation was carried out in a 1 cm quartz cuvette in a low-
temperature chamber set with a UV-visible absorption spectrometer
and monitored by absorption spectral change. Finally, excess ozone
gas was removed by bubbling argon gas with a gastight syringe.
Kinetics and Product Analysis. Oxoiron(IV) porphyrin π-cation
radical (100 µM) in dichloromethane was prepared in a 1 cm quartz
cuvette in a low-temperature chamber set with a UV-visible
absorption spectrometer, as described above. An excess of cy-
clooctene (20-1000 equiv) was then added to the solution with
vigorous stirring, and the reactions were monitored by the absorption
spectral change at constant time intervals. After confirming the
completion of the reactions, 10 equiv of tetrabutylammonium iodide
(n-Bu4N+I-) was added to the solution at the same temperature.
After warming to room temperature, quantitative product analyses
were subsequently performed with GC-MS using undecane as an
internal standard. The reaction rate constants were determined by
computer simulation of absorption versus time for the reactions.
1
498, 526, and 619 nm. (TMTMP)FeIII(3-F-4-NO2-PhO); H NMR
(CD2Cl2, 25 °C), -47.0 (meso-H), 4.5 and 7.3 (ortho-Me), 11.9
and 12.0 (meta-H), 5.0 (para-Me), 47.0 (pyrrole-Me), -83.1 and
-79.9 (phenol ortho-H), 67.9 (phenol meta-H). 19F NMR (CD2Cl2,
25 °C), 58.3 (meta-F). UV-vis. (CH2Cl2, 25 °C), 370, 401, 496,
524, and 619 nm.
Iron(III) Monoimidazole Complexes. Iron(III) porphyrin
monoimidazole complex was generated in situ by adding 1.0 equiv
of imidazole, 2-methylimidazole, or 4-methylimidazole to perchlo-
rate iron(III) porphyrin in dichloromethane.49 [(TMP)FeIII(Im)]ClO4;
1H NMR (CD2Cl2, 25 °C), 3.1 and 5.3 (ortho-Me), 12.6 and 13.4
(meta-H), 4.3 (para-Me), 19.9 (pyrrole-H), -15.5 (Im 2-H), 30.1
(Im 4-H), 85.1 (Im 5-H), 100.4 (Im N-H). UV-vis. (CH2Cl2, 25
1
°C), 412, 510, 575, and 690 nm. [(TMP)FeIII(2-MeIm)]ClO4; H
NMR (CD2Cl2, 298K), 2.7 and 5.7 (ortho-Me), 12.7 and 13.1 (meta-
H), 4.1 (para-Me), 34.9 (pyrrole-H), 16.6 (2-MeIm 2-Me), 31.8
(2-MeIm 4-H), 65.8 (2-MeIm 5-H), 109.0 (2-MeIm N-H).
Acknowledgment. This work was supported by grants
from the Japan Science and Technology Agency, CREST,
and from the Ministry of Education, Culture, Sports, Science
and Technology, Japan, the Global COE program.
(46) Reed, C. A.; Mashiko, T.; Bentley, S. P.; Kastner, M. E.; Scheidt,
W. R.; Spartalian, K.; Lang, G. J. Am. Chem. Soc. 1979, 101, 2948–
2958.
(47) Phillippi, M. A.; Baenziger, N.; Goff, H. M. Inorg. Chem. 1981, 20,
3904–3911.
(48) (a) Tang, S. C.; Koch, S.; Papaefthymiou, G. C.; Foner, S.; Frankel,
R. B.; Ibers, J. A.; Holm, R. H. J. Am. Chem. Soc. 1976, 98, 2414–
2434. (b) Ainscough, E. W.; Addison, A. W.; Dolphin, D.; James,
B. R. J. Am. Chem. Soc. 1978, 100, 7585–7591.
(49) (a) Quinn, R.; Nappa, M.; Valentine, J. S. J. Am. Chem. Soc. 1982,
104, 2588–2595. (b) Scheidt, W. R.; Geiger, D. K.; Lee, Y. J.; Reed,
C. A.; Lang, G. J. Am. Chem. Soc. 1985, 107, 5693–5699.
Supporting Information Available: Text (PDF) containing
additional figures (Figure S1-S17) and tables (Tables S1 and S2).
This material is available free of charge via the Internet at
IC802123M
Inorganic Chemistry, Vol. 48, No. 6, 2009 2625